Hydralazine HCL is a medication used to treat high blood pressure and heart failure. This includes high blood pressure in pregnancy and very high blood pressure resulting in symptoms. The mucoadhesive buccal tablets of Hydralazine HCL were papered by direct compression method using natural and synthetic polymer like Pectin, Sodium alginate and Carbopol. The compatibility studies of drug and excipient were performed by FT-IR spectroscopy. After examining the flow properties of the powder blends the results were found to be within prescribed limits and indicated good flowing property, hence it was subjected to compression. The tablets were evaluated for post-compression parameters like weight variation, hardness, thickness, friability, drug content uniformity, surface pH, in-vitro studies like Moisture absorption and drug release. Formulation (H2) containing Pectin showed exhibited optimum drug release (99.32%). Surface pH was found to be range of salivary pH. All the evaluation parameters given the positive result and comply with the standards.
Cite this article:
Y. Krishna Reddy, P. Shirisha. Formulation and In-vitro Evaluation of Buccal Tablets of Hydralazine HCl. Res. J. Pharma. Dosage Forms and Tech.2020; 12(3):150-154. doi: 10.5958/0975-4377.2020.00025.7
1. V. T. Iswariya and A. Hari Om Prakash Rao. Buccal Tablets A Comprehensive Review. ejpmr, 2016,3(8), 252-262.
2. S.K.Gupta et al; Buccal adhesive drug delivery system: A review; Asian Journal Of Biochemical and pharmaceutical research, 2011;1(2): 105-114.
3. Reena Sheoran. Buccal Drug Delivery System: A Review. Int. J. Pharm. Sci. Rev. Res., 50(1), May - June 2018; Article No. 07, Pages: 40-46.
4. Wertz, P.W. and Squier, C.A., Cellular and molecular basis of barrier function in oral epithelium, Crit. Rev. Ther. Drug Carr. Sys, 8, 1991, 237-269.
5. Squier, C.A., Cox, P., and Wertz, P.W., Lipid content and water permeability of skin and oral mucosa, The J. Invest. Dermat, 96, 1991, 123-126.
6. Squier, C.A. and Wertz, P.W. Structure and function of the oral mucosa and implications for drug delivery, in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, New York, 1996, 1-26.
7. Galey, W.R., Lonsdale, H.K., and Nacht, S., The in vitro permeability of skin and buccal mucosa to selected drugs and J Pharm Pharmaceut Sci (www.ualberta.ca/~csps) 1 (1), 1998, 15-30.